Figure 2.

The unique features of early-treated children as a model. The panel summarises the main differences among early-treated children and other model populations. HIV-infected infants treated within 2–3 months of life rarely exhibit HIV-specific immunity, have a more limited viral reservoir and viral diversity, greater thymic output, lower numbers of central memory T cells and greater ability to develop and maintain protective responses to vaccination, compared with other population models